文献库搜索 | GeneLibs

Baraian(CS),Turculet(CS),Negoi(I) Cancers (Basel) 2026-03-18

...BRCA1/2, MLH1, and MSH2. We aimed to evaluate the risk of pancreatic cancer associated with inherited genetic mutations ...

Ugrinovski(D),Saidi(S),Stankov(V),Ambardji... Cancers (Basel) 2026-03-22

...BRCA1 and ALK, were also detected, reflecting the extended coverage of the panel. TP53 mutations were independently asso...

Huang(L),Yang(Y),Duan(D),Dai(L),Zhai(B),Qi... Molecules 2026-03-20

...BRCA1 and RAD51, which may contribute to impaired DNA-damage repair and increased sensitivity to Olaparib. In summary, t...

Xu(L),Kong(X),Zhang(B),Ma(H),Li(X),Deng(Y)... Pharmaceutics 2026-03-12

...BRCA1/2 alterations develop resistance, and patient eligibility remains limited by the low prevalence of HRD mutations. ...

Zhang(J),Zhang(Z),Xia(X),Feng(K),Yao(S),Wa... Pharmaceutics 2026-03-19

...BRCA1, RAD51, and SLFN11, in a manner consistent with impaired DNA repair capacity. In vivo, high-dose SANE-TZL achieved...

Berardi(V),Muslimov(IA),Sun(D),Militello(G... iScience 2026-04-17

...BRCA1 mRNA, BC200 RNA reduces BRCA1 protein expression in breast epithelial cells, leading to increased DNA damage and c...

Saleem(KM),Amirova(MF),Rahimov(JA),Musayev... Eur J Breast Health 2026-06-17

...BRCA1/2-mutant and homologous recombination-deficient tumors, are being extended through rational combinations that inte...

Mavaddat(N),Barnes(DR),Michailidou(K),Zhao... Br J Cancer 2026-05-00

...BRCA1, and between AAM and BC risk in BRCA1 and BRCA2 PV carriers. These results may aid risk prediction models and gene...

Bistriceanu(I),Ungureanu(CO),Stoica(RA),Gi... Maedica (Bucur) 2026-03-00

...BRCA1 and BRCA2) remain central to hereditary breast and ovarian cancers, progress in cancer genetics has shifted clinic...

Baltayev(N),Abdikerim(S),Afonin(G),Rasulov... Sci Rep 2026-04-14

...BRCA1 (6.46%). Missense (35.5%) and frameshift (32.3%) variants predominated. A high number of PVs was found in individu...